2010
DOI: 10.1211/jpp.62.01.0001
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus

Abstract: Pharmacokinetic studies of drugs in patients with type I diabetes mellitus were scarce. Moreover, similar and different results for drug pharmacokinetics were obtained between diabetic rats and patients with type I diabetes mellitus. Thus, present experimental rat data should be extrapolated carefully in humans.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
54
0
4

Year Published

2010
2010
2018
2018

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(63 citation statements)
references
References 157 publications
(384 reference statements)
2
54
0
4
Order By: Relevance
“…The results on FBG level support the views that streptozotocin increases blood glucose in rats (Altay et al, 2003;Gunelli et al, 2008;Lee et al, 2010;Fernandes et al, 2011) to cause type I diabetes mellitus and that chronic fructose consumption through insulin resistance mechanism causes type II diabetes mellitus (Arikawe et al, 2006). The results also show that ginger exhibits some hypoglyceamic effects (Akhani et al, 2004;Kadnur and Goyal, 2005;Al-Amin et al, 2006;Iranloye et al, 2011).…”
Section: Discussionsupporting
confidence: 76%
“…The results on FBG level support the views that streptozotocin increases blood glucose in rats (Altay et al, 2003;Gunelli et al, 2008;Lee et al, 2010;Fernandes et al, 2011) to cause type I diabetes mellitus and that chronic fructose consumption through insulin resistance mechanism causes type II diabetes mellitus (Arikawe et al, 2006). The results also show that ginger exhibits some hypoglyceamic effects (Akhani et al, 2004;Kadnur and Goyal, 2005;Al-Amin et al, 2006;Iranloye et al, 2011).…”
Section: Discussionsupporting
confidence: 76%
“…A diabetic animal model induced by STZ has been widely used in pharmacokinetic studies (Sato et al, 1991;Shimojo et al, 1993;Ogata et al, 1996;Lee et al, 2010;Liu et al, 2010;Yu et al, 2010a), but the real mechanism altering the pharmacokinetics of drugs is unclear. Several studies demonstrated that changes in pharmacokinetics in diabetic rats induced by STZ is mainly due to the indirect effect of STZ (Ioannides et al, 1996;Lee et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…Several studies demonstrated that changes in pharmacokinetics in diabetic rats induced by STZ is mainly due to the indirect effect of STZ (Ioannides et al, 1996;Lee et al, 2010). The complications from any toxic effects of STZ were negligible 4 to 5 weeks after STZ injection (Watkins and Sherman, 1992).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Since the solutions of alloxan and streptozotocin are relatively unstable, they should be prepared immediately before the injection. Note that these substances can possess different degrees of toxicity with respect to other organs, too [9,90,91]. Besides the destruction of beta cells, alloxan and streptozotocin are capable of modifying biological macromolecules and DNA fragmenting [9,10,11,89].…”
Section: Experimental Models Of Diabetes Mellitusmentioning
confidence: 99%